The role of epoxide hydrolase Y113H gene variant in pancreatic diseases

Pancreas

Volumn 38, Issue 4, 2009, Pages

  Ockenga, Johann ^a,g   Strunck, Sebastian ^a   Post, Cora ^a   Schulz, Hans Ulrich ^b   Halangk, Juliane ^a   Pfützer, Roland H ^c   Löhr, Matthias ^d   Oettle, Helmut ^a   Kage, Andreas ^a   Rosendahl, Jonas ^e   Keim, Volker ^e   Drenth, Joost P H ^f   Jansen, Jan B M J ^f   Lochs, Herbert ^a   Witt, Heiko ^a,h  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c Universität Magdeburg ^*  (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^g KLINIKUM BREMEN MITTE   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute pancreatitis; Chronic pancreatitis; EPHX1; Epoxide hydrolase; Pancreatic cancer; Polymorphism

Indexed keywords

EPOXIDE HYDROLASE; GENOMIC DNA; EPHX1 PROTEIN, HUMAN;

ACUTE PANCREATITIS; ADULT; ALCOHOLIC PANCREATITIS; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DNA POLYMORPHISM; EPOXIDE HYDROLASE GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SMOKING; ACUTE DISEASE; ADENOCARCINOMA; ADOLESCENT; AGED; CHILD; ENZYMOLOGY; GENETICS; MIDDLE AGED; MISSENSE MUTATION; PANCREAS DISEASE; PANCREAS TUMOR;

ACUTE DISEASE; ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CHILD; EPOXIDE HYDROLASES; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; GERMANY; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; NETHERLANDS; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; PANCREATITIS, ALCOHOLIC; PANCREATITIS, CHRONIC; RISK FACTORS; YOUNG ADULT;

EID: 66149088105     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31819feeed     Document Type: Article

References (34)

1. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis and treatment of pancreatic ductal adenocarcinoma. Gastroenterology. 1999;117:1464-1484.
2. Lowenfels AB, Maisonneuve P, Whitcomb DC, et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA. 2001;286:169-170. (Pubitemid 32640846)
3. Ji BT, Silverman DT, Stewart PA, et al. Occupational exposure to pesticides and pancreatic cancer. Am J Ind Med. 2001;39:92-99. (Pubitemid 32044136)
4. Talamini G, Bassi C, Falconi M, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci. 1999;44:1303-1311. (Pubitemid 29404289)
5. Lowenfels AB, Maisonneuve P, Lankisch PG. Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am. 1999;28:673-685. (Pubitemid 29439470)
6. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14:141-145. (Pubitemid 26338792)
7. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998; 339:645-652. (Pubitemid 28402088)
8. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998;339:653-658. (Pubitemid 28402089)
9. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000;25:213-216.
10. Rosendahl J, Witt H, Szmola R, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008;40:78-82.
11. Witt H, Sahin-Toth M, Landt O, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38:668-673. (Pubitemid 43927309)
12. Anderson KE, Hammons GJ, Kadlubar FF, et al. Metabolic activation of aromatic amines by human pancreas. Carcinogenesis. 1997;18:1085-1092. (Pubitemid 28132359)
13. Foster JR, Idle JR, Hardwick JP, et al. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol. 2002;169:457-463.
14. Braganza JM. A framework for the aetiogenesis of chronic pancreatitis. Digestion. 1998;59(suppl 4):1-12.
15. Morisseau C, Hammock BD. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol. 2005;45:311-333. (Pubitemid 40261808)
16. Coller JK, Fritz P, Zanger UM, et al. Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours. Histochem J. 2001;33:329-336. (Pubitemid 33078968)
17. Miyata M, Kudo G, Lee YH, et al. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[α]anthracene. J Biol Chem. 1999;274:23963-23968. (Pubitemid 129528438)
18. Hassett C, Aicher L, Sidhu JS, et al. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994;3:421-428. (Pubitemid 24083901)
19. Kiyohara C, Yoshimasu K, Takayama K, et al. EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology. 2006; 17:89-99. (Pubitemid 43755785)
20. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, et al. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res. 2000;60:534-536. (Pubitemid 30094545)
21. Harrison DJ, Hubbard AL, MacMillan J, et al. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer. 1999;79:168-171. (Pubitemid 28566943)
22. Wong NA, Rae F, Bathgate A, et al. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol Lett. 2000;115:17-22. (Pubitemid 30417451)
23. Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997;350:630-633. (Pubitemid 27367797)
24. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11Y13, 1992. Arch Surg. 1993;128:586-590.
25. Rodriguez F, Jardi R, Costa X, et al. Detection of polymorphisms at exons 3 (Tyr113→His) and 4 (His139→Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis. Anal Biochem. 2002;308:120-126. (Pubitemid 35191645)
26. Rahman SH, Nanny C, Ibrahim K, et al. Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity. Dig Dis Sci. 2005;50:1376-1383. (Pubitemid 41184772)
27. Rahman SH, Ibrahim K, Larvin M, et al. Association of antioxidant enzyme gene polymorphisms and glutathione status with severe acute pancreatitis. Gastroenterology. 2004;126:1312-1322. (Pubitemid 38552796)
28. Bartsch H, Malaveille C, Lowenfels AB, et al. Genetic polymorphism of N-actyltransferase, glutathione S transferase M1 and NAD(P) H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. Eur J Cancer Prev. 2002;7:215-223.
29. Verlaan M, te Morsche RH, Roelofs HM, et al. Glutathione S-transferase Mu null genotype affords protection against alcohol induced chronic pancreatitis. Am J Med Genet A. 2003;120:34-39. (Pubitemid 37063829)
30. Duell EJ, Holly EA, Bracci PM, et al. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst. 2002; 94:297-306.
31. Ockenga J, Vogel A, Teich N, et al. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology. 2003;124:1802-1808. (Pubitemid 36666777)
32. Verlaan M, Drenth JP, Truninger K, et al. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet. 2005;42:e62.
33. Hattersley A, McCarthy MI. What makes a good genetic association study? Lancet. 2005;366:1315-1323.
34. Hosagrahara VP, Rettie AE, Hassett C, et al. Functional analysis of human microsomal epoxide hydrolase genetic variants. Chem Biol Interact. 2004;150:149-159. (Pubitemid 39463278)